Occurrence of both breast and ovarian cancer in a woman is a marker for the BRCA gene mutations: A population-based study from Western Sweden

Familial Cancer

Volumn 6, Issue 1, 2007, Pages 35-41

  Einbeigi, Zakaria ^a   Bergman, Annika ^a   Meis Kindblom, Jeanne M ^a   Flodin, Anna ^a   Bjursell, Cecilia ^a   Martinsson, Tommy ^a   Kindblom, Lars Gunnar ^a   Wahlström, Jan ^a   Wallgren, Arne ^a   Nordling, Margareta ^a   Karlsson, Per ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

BRCA; Breast cancer; Hereditary; Ovarian cancer; Population based study

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; PARAFFIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER INVASION; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; FOUNDER EFFECT; GENE MUTATION; GENETIC COUNSELING; GENETIC MARKER; GEOGRAPHIC DISTRIBUTION; GRANULOSA CELL TUMOR; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ONSET AGE; OVARY CANCER; OVARY CARCINOMA; OVARY TUMOR; POPULATION GENETICS; PRIORITY JOURNAL; SCANDINAVIA; SWEDEN; THECOMA;

AGE OF ONSET; BREAST NEOPLASMS; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC SCREENING; GENETICS, POPULATION; HUMANS; MUTATION; NEOPLASMS, SECOND PRIMARY; NEOPLASTIC SYNDROMES, HEREDITARY; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SWEDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 33847165720     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-006-9101-0     Document Type: Article

References (25)

1. Peto J, Collins N, Barfoot R et al (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91(11):943-949
2. Thorlacius S, Struewing JP, Hartge P et al (1998) Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet 352(9137):1337-13379
3. Neuhausen SL (1999) Ethnic differences in cancer risk resulting from genetic variation. Cancer 86(Suppl 11):2575-2582
4. Tobias DH, Eng C, McCurdy LD et al (2000) Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients. Gynecol Oncol 78(2):148-151
5. Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A (2001) Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst 93(16):1215-1223
6. Hirsh-Yechezkel G, Chetrit A, Lubin F et al (2003) Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israel. Gynecol Oncol 89(3):494-498
7. Johannsson O, Ostermeyer EA, Hakansson S et al (1996) Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Am J Hum Genet 58(3):441-450
8. Einbeigi Z, Bergman A, Kindblom LG et al (2001) A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer. Eur J Cancer 37(15):1904-1909
9. Bergman A, Flodin A, Engwall Y et al (2005) A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniques. Fam Cancer 4:89-96
10. Bergman A, Einbeigi Z, Olofsson U et al (2001) The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation. Eur J Hum Genet 9(10):787-793
11. Bergfeldt K, Rydh B, Granath F et al (2002) Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study. Lancet 360(9337):891-894
12. Einbeigi Z, Meis-Kindblom JM, Kindblom LG, Wallgren A, Karlsson P (2002) Clustering of individuals with both breast and ovarian cancer - a possible indicator of BRCA founder mutations. Acta Oncol 41(2):153-157
13. World Health Organisation (1957) ICD-7. International classification of diseases, injuries and causes of death. 1955 revision, Geneva
14. den Dunnen JT, Antonarakis SE (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15(1):7-12
15. Deffenbaugh AM, Frank TS, Hoffman M, Cannon-Albright L, Neuhausen SL (2002) Characterization of common BRCA1 and BRCA2 variants. Genet Test 6(2):119-121
16. Welcsh PL, King MC (2001) BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet 10(7):705-713
17. Williams C, Pontén F, Moberg C et al (1999) A high frequency of sequence alterations is due to formali fixation of archival specimens. Am J Pathology 155:1467-1471
18. Bergfeldt K, Silfversward C, Einhorn S, Hall P (2000) Overestimated risk of second primary malignancies in ovarian cancer patients. Eur J Cancer 36(1):100-105
19. Johannsson OT, Idvall I, Anderson C et al (1997) Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur J Cancer 33(3):362-371
20. Malander S, Ridderheim M, Masback A et al (2004) One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden. Eur J Cancer 40(3):422-428
21. Sarantaus L, Auranen A, Nevanlinna H (2001) BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families. Int J Oncol 18(4):831-835
22. King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643-646
23. Bergthorsson JT, Ejlertsen B, Olsen JH et al (2001) BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age. J Med Genet 38(6):361-368
24. Margolin S, Werelius BF, Fornander T, Lindblom A (2004) BRCA1 mutations in a population-based study of breast cancer in Stockholm County. Genet Test 8:127-132
25. Dørum A, Hovig E, Trope C, Inganas M, Moller P (1999) Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA. Eur J Cancer 35(5):779-781